Drugmakers are racing to find medicines that can curb the spread of the coronavirus as the infection bypasses China’s travel restrictions.
Pharmaceutical companies from Gilead Sciences Inc. to Moderna Inc. are pursuing two main strategies: helping to re-purpose medicines developed against o
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
